Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III–IV acute graft-versus-host disease, systemically treated chronic graft-versus-host disease, relapse, and death, is a novel, meaningful composite end point for clinical trials. To characterize risk fact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Inamoto, Yoshihiro, Kimura, Fumihiko, Kanda, Junya, Sugita, Junichi, Ikegame, Kazuhiro, Nakasone, Hideki, Nannya, Yasuhito, Uchida, Naoyuki, Fukuda, Takahiro, Yoshioka, Kosuke, Ozawa, Yukiyasu, Kawano, Ichiro, Atsuta, Yoshiko, Kato, Koji, Ichinohe, Tatsuo, Inoue, Masami, Teshima, Takanori
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5479609/
https://ncbi.nlm.nih.gov/pubmed/27662017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.149427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados